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Abstract
A high degree of vigilance and appropriate diagnostic methods are required to detect
Clostridioides difficile infection (CDI). We studied the effectiveness of a multimodal training
program for improving CDI surveillance and prevention. Between 2011 and 2016, this pro-
gram was made available to healthcare staff of acute care hospitals in Catalonia. The program
included an online course, two face-to-face workshops and dissemination of recommenda-
tions on prevention and diagnosis. Adherence to the recommendations was evaluated through
surveys administered to the infection control teams at the 38 participating hospitals. The
incidence of CDI increased from 2.20 cases/10 000 patient-days in 2011 to 3.41 in 2016
(P < 0.001). The number of hospitals that applied an optimal diagnostic algorithm rose
from 32.0% to 71.1% (P = 0.002). Hospitals that applied an optimal diagnostic algorithm
reported a higher overall incidence of CDI (3.62 vs. 1.92, P < 0.001), and hospitals that
were more active in searching for cases reported higher rates of hospital-acquired CDI
(1.76 vs. 0.84, P < 0.001). The results suggest that the application of a multimodal training
strategy was associated with a significant rise in the reporting of CDI, as well as with an
increase in the application of the optimal diagnostic algorithm.
Introduction
Clostridioides difficile (formerly Clostridium difficile) is the most frequent cause of
healthcare-related infectious diarrhoea, which mainly affects elderly patients presenting risk
factors such as the use of antibiotics [1]. Patients are exposed to spores of the organism
through contact with the hands of the health personnel or the hospital environment [2].
The diagnosis of Clostridioides difficile infection (CDI) is based on clinical suspicion and
on the application of adequate laboratory techniques. In recent years, microbiological diagno-
sis has been enhanced by the incorporation of more sensitive tests in diagnostic algorithms
such as molecular techniques [3]. The prevention of CDI in the healthcare setting depends
on early diagnosis and the application of a set of measures including hand hygiene and the
cleaning and disinfection of surfaces, and the proper use of antibiotics [1].
In developed countries, the incidence of CDI, including CDI of nosocomial origin, has
risen in recent years [4–6]. However, according to a study conducted in Europe between
2011 and 2013, its incidence varies across countries from 0 to 36.3/10 000 patient-days [7],
due in part to the low diagnostic suspicion and the application of suboptimal diagnostic
methods; in fact, in that study, only 52% of hospitals used an optimal diagnostic algo-
rithm [7]. The training of health professionals is fundamental in CDI prevention pro-
grams in order to improve the detection of cases and to increase compliance with preventive
measures [8].
The aim of this study was to evaluate the effectiveness of a multimodal training program in
improving the surveillance and prevention of CDI in hospitals participating in the nosocomial
infection surveillance program in Catalonia (VINCat) [9].
Methods
This multicentre, prospective, quasi-experimental study designed by the VINCat program’s
CDI study group assessed the multimodal training program by comparing the baseline
phase (2011) with the post-training phase (2016). The items evaluated were the evolution
of the number of hospitals participating in the CDI surveillance program, the evolution of
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the CDI rates reported, the percentage of centres using appropri-
ate CDI diagnostic methodology and the adequacy of the preven-
tion measures applied at each centre.
Study setting
VINCat is a nosocomial infection surveillance and control pro-
gram which has been in operation at acute care hospitals in
Catalonia since 2006 [9]. The present study was carried out in
the hospitals in the VINCat program that reports cases of CDI.
All these hospitals have multidisciplinary infection control
teams, and they are stratified into three groups according to
size: group 1 (more than 500 beds), group 2 (between 200 and
500 beds) and group 3 (fewer than 200 beds).
Intervention
Between 2011 and 2015, a multimodal training program was
implemented, which comprised the following elements:
(1) An online course for physicians, microbiologists and nursing
staff at Catalan hospitals. The course consisted of five parts:
epidemiology and clinical manifestations of CDI; microbio-
logical and non-microbiological diagnosis; transmission
mechanisms, surveillance and prevention measures; treatment
of diarrhoea associated with C. difficile; and CDI in special
populations. Each section included a text, summaries, algo-
rithms, images and recommendations for further reading,
and ended with a test that participants had to complete before
proceeding to the next section.
(2) Participation was voluntary. Healthcare professionals from all
hospitals in Catalonia could participate in the course, regard-
less of whether they reported or not cases of CDI to the
VINCat program. The course was promoted by means of leaf-
lets, e-mails to the coordinators of the centres and members
of the Catalan Association of Infection Control Nurses, at
congresses and scientific workshops and on the VINCat pro-
gram website.
(3) Participants could access a student and tutor forum where
they could ask and answer questions. Immediately after the
study period, they were asked to answer a multi-choice quiz
with 10–12 questions, each one with a correct answer and
three distractors: one point was awarded for a correct answer
and zero points for an incorrect or no answer. The result was
provided at the end of the test. The course was offered five
times; in all, 890 health professionals participated.
(4) Face-to-face training. Two workshops were conducted for the
staff of the hospitals (physicians, microbiologists and nurses)
participating in the VINCat program: the first in 2011,
attended by 129 participants, and the second in 2013,
attended by 149 participants. The workshops included feed-
back on the incidence rates of CDI at the participating hospi-
tals, measures to prevent transmission and discussion of
practical cases with regard to surveillance criteria and micro-
biological diagnosis.
(5) Preparation (and dissemination via the VINCat program
website) of recommended transmission prevention measures,
the microbiological diagnostic algorithm, information on CDI
for patients and relatives, a checklist for cleaning and disinfec-
tion of surfaces possibly contaminated by C. difficile, and
recommended further reading.
(6) Participants’ satisfaction survey regarding the training activ-
ities, evaluating: online training, the diagnostic algorithm,
recommended precautions, information for the patient, the
checklist of cleaning and disinfection of surfaces, recom-
mended bibliography and feedback on the incidence rates
reported by hospitals. A numerical scale from 1 to 5 was
used (1: not very useful, 5: very useful), with scores 4 and 5
indicating a high level of satisfaction.
CDI surveillance
Cases of CDI were followed up continuously from 2011 to 2016,
using the methodology previously defined by the VINCat
program.
Population under surveillance: adults over 18 years of age
attended in any hospital sector (wards, emergency services, out-
patient consultations, etc.) who met the definition of CDI.
Asymptomatic patients were excluded, even if they were carriers
of a toxin-producing strain, as were patients with a history of
CDI and those at specific palliative care or convalescence units.
Definition of CDI: a patient with acute diarrhoea (defined as
three or more unformed bowel movements in 24 h), or toxic
megacolon without another known cause, plus one of the follow-
ing: (1) stool sample with a toxin A- or B-positive laboratory
result for C. difficile, or detection of genes that encodes toxin by
molecular testing; (2) endoscopic, surgical or histological examin-
ation confirming the diagnosis of pseudomembranous colitis.
Classification according to the site of acquisition of diarrhoea
Hospital-acquired CDI: infection identified >48 h after admission
to the hospital and before discharge.
Non-nosocomial healthcare-related CDI: infection starting in
the community or within 48 h of admission, in patients admitted
to a health centre (hospital, nursing home or community health
centre) in the 4 weeks prior to the onset of symptoms.
Community-acquired CDI: infection starting in the commu-
nity or within 48 h of admission, with no admission to a health
centre in the last 4 weeks.
Incidence rates were expressed in the number of cases per 10
000 patient-days.
The coordinating centre provided feedback to each hospital on
an annual basis, reporting their rates and comparing them with
the rest of the hospitals (means, medians and percentiles) and
according to the size of the hospital.
Survey of adherence to recommendations
To assess adherence to the recommended diagnostic methods and
preventive measures, a self-administered questionnaire was used
in 2011 (baseline measurement) and 2016 (post-training meas-
urement). A group of infection control experts validated the con-
tent and structure of the questionnaire for comprehensibility and
consistency. The questionnaire had two sections, the first with
nine questions on diagnostic aspects and the second with seven
questions on preventive measures. The 2016 questionnaire also
incorporated the satisfaction survey on the different training activ-
ities and instruments provided. The questionnaire was distributed
electronically by the coordinating centre, and the results were
entered into a database for further analysis. The diagnostic meth-
odology was considered optimal when an algorithm including two
or more detection methods for toxigenic C. difficile was applied.
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The most frequently used algorithm was the one that detected the
GDH enzyme by enzyme-linked immunosorbent assay as a
screening method, followed by the detection of the A/B toxin
either by enzyme-linked immunosorbent assay or by molecular
methods. Search intensity (i.e. the attention paid to identifying
CDI cases) was considered adequate when the presence of toxi-
genic C. difficile was investigated in more than 80% of cases of
nosocomial diarrhoea. The survey was answered by the person
in charge of the infection control team at each hospital, after dis-
cussing it with the team members (clinicians, nurses and
microbiologists).
Statistical analysis
CDI incidence rates are expressed as the number of CDI cases per
10 000 patient-days, with 95% confidence intervals (95% CI).
Descriptive analysis was performed using counts and percentages
for categorical and stratified continuous variables.
To evaluate the impact of the training program, we compared
the number of participating hospitals and the incidence density
rate of CDI reported by the hospitals over the period between
2011 and 2016. To assess the impact of the intervention on diag-
nostic methods and prevention measures, we compared the com-
pliance rates observed in the initial and the post-training surveys.
In 2016, at the end of the study, CDI incidence rates were com-
pared in hospitals that applied an optimal diagnostic method-
ology and in hospitals that applied a suboptimal methodology.
Likewise, the rates of hospital-acquired CDI were compared
between hospitals with an adequate search intensity and hospitals
with a lower intensity. For the comparison of proportions, the χ2
test or Fisher’s exact test was used, as appropriate. For the
comparison of the annual CDI incidence rates, the Cochran–
Armitage trend test was used. A P value of 0.05 or less was
considered statistically significant. For the statistical analysis, the
EPIDAT V 3.1 program was used.
Results
The number of hospitals reporting CDI rates to the VINCat pro-
gram rose from 29 in 2011 to 47 in 2016. Of these, 25 centres
completed the survey in 2011 (seven with >500 beds, 13 with
200–500 beds and five with <200 beds) and 38 centres in 2016
(five with >500 beds, 13 with 200–500 beds and 20 with <200
beds).
During the 6 years of the study, 4931 cases of CDI were
reported, of which 2196 (44.5%) were hospital-acquired, 1518
(30.8%) non-nosocomial healthcare-related and 1217 (24.7%)
community-acquired. Table 1 shows the evolution of the reported
incidence of CDI. There was a significant and constant increase in
the overall incidence reported by the group of hospitals between
2011 and 2016. This increase was also observed for hospital-
acquired CDI, non-nosocomial healthcare-related CDI and
community-acquired CDI. This constant and significant upward
trend was also observed when only the hospitals that reported
cases since 2011 were considered (Table 2).
Table 3 shows the results of the surveys on CDI diagnosis and
prevention. With regard to the diagnostic methods, a significant
increase in the application of the optimal diagnostic algorithm
was observed. There was an increase in the search intensity for
CDI in patients admitted from nursing homes or from commu-
nity health centres and in patients with community-acquired



































































































































































































































































































































































































































































Epidemiology and Infection 3
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268819001080
Downloaded from https://www.cambridge.org/core. IP address: 139.59.165.54, on 26 Oct 2020 at 09:27:11, subject to the Cambridge Core terms of use, available at
measures recommended, although the differences did not reach
statistical significance.
Focusing solely on the seven hospitals that already used an
optimal diagnostic algorithm in 2011 and presented an adequate
search intensity, the overall incidence of CDI did not change sig-
nificantly over the study period (from 3.51 cases/10 000 patient-
days (95% CI 3.09–3.92) in 2011 to 2.96 (95% CI 2.60–3.32) in
2016, P = 0.054); nor were there significant changes in the inci-
dence of hospital-acquired CDI (from 1.74 (95% CI 1.45–2.03)
in 2011 to 1.43 (95% CI 1.18–1-68) in 2016, P = 0.122).
In 2016, the incidence of CDI reported by hospitals that used
an optimal diagnostic methodology (3.62 cases/10 000 patient-
days, 95% CI 3.34–3.90) was higher than that reported by hospi-
tals that used a suboptimal methodology (1.92 cases/10 000
patient-days, 95% CI 1.42–2.41, P < 0.001). Likewise, the inci-
dence of hospital-acquired CDI reported by hospitals with an
adequate search intensity (1.76 cases/10 000 patient-days, 95%
CI 1.55–1.97) was higher than that reported by the hospitals
with a lower search intensity (0.84 cases/10 000 patient-days,
95% CI 0.61–1.08, P < 0.001).
Thirty-eight hospitals answered the survey on the degree of
satisfaction among health staff in relation to the training tools
and documents provided. The rates of responses with a high
degree of satisfaction (4 or 5 on a scale of 1 to 5) were 97.2%
for the online training course, 94.1% for the annual feedback
on the centre’s results, 94.1% for the recommendations for pre-
ventive measures on the website, 93.9% for the diagnostic algo-
rithm, 87.5% for the recommended further reading, 85.7% for
the information document for patients and relatives and 70.0%
for the checklist of the cleaning and disinfection of surfaces in
contact with patients with CDI.
Discussion
The training of health professionals is essential to the success of
programs for the prevention of nosocomial infections, including
CDI [8]. Previous research has reported a lack of knowledge of
CDI among healthcare professionals [10].
In the present study, training provided as part of a program of
CDI surveillance and control was associated with significant
increases in the use of the most sensitive diagnostic algorithm
and in the rate of CDI cases reported at hospitals participating
in the VINCat program in Catalonia, and with greater compliance
with diagnostic and preventive protocols. The training activity
was also associated with a rise in the number of hospitals partici-
pating in the CDI surveillance program, probably due to the par-
ticipation of the hospital infection control teams in the training
program.
The mean incidence of CDI reported in Catalonia in 2016
(3.41 cases/10 000 patient-days) is similar to the rates in other
Mediterranean countries and lower than those reported in nor-
thern Europe [11–13]. In the present study, there was a significant
increase in all three types of CDI from 2011 to 2016 –
hospital-acquired, non-nosocomial healthcare-related and (above
all) in community-acquired infections. This increase in the inci-
dence of CDI has been reported in other studies and has been
associated with the implementation of more sensitive diagnostic
techniques [13]. In this regard, our analysis of the evolution of
the incidence of CDI reported by hospitals which already used
an optimal diagnostic algorithm in 2011 and presented an
adequate search intensity showed no increase in incidence over
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observed in the study as a whole is due to the improvements in the
diagnostic methods recorded in most hospitals. The use of sub-
optimal diagnostic methods is a limiting factor in the diagnosis
of CDI; in agreement with other studies [14], we found the
mean incidence of CDI reported by hospitals that applied an opti-
mal diagnostic methodology (with a two-or-three step algorithm)
to be significantly higher than at hospitals that did not. The
incorporation of PCR to the diagnostic algorithm increases the
detection of cases, due to its greater sensitivity [12, 15], although
it is important to restrict the study to liquid or semi-liquid stools
(as our participating centres did) in order to avoid the diagnosis
of CDI in asymptomatic patients carrying C. difficile.
The lack of clinical suspicion is another fundamental factor in
CDI underdiagnoses, which may occur in as many as 25% of
cases. In a multinational European study, when CDI was system-
atically investigated in all faecal samples from patients with diar-
rhoea referred to the Microbiology laboratory regardless of
whether the physician had asked for the test, it was found that
in 23% of the cases of detected CDI, the study of C. difficile
had not been requested [7]. Probably, in these cases, clinicians
had suspected other causes of diarrhoea. In our study, hospitals
with adequate search intensity for nosocomial CDI reported a
significantly higher incidence than the rest.
The incidence of CDI in patients from community health cen-
tres is little known and probably underdiagnosed, although these
patients may be a source of transmission of infection in acute care
hospitals [16]. The training carried out increased clinical suspi-
cion (though the difference was not statistically significant) in
patients referred from nursing homes or from community health
centres.
The incidence of community-acquired CDI practically doubled
during the period of the study, probably in relation to the increase
in search intensity in patients with previous antibiotic treatment.
However, a recent study found that only 36% of community-
acquired CDIs had received antibiotics [17], and so other risk
factors must be considered [18].
Early notification by the microbiologist, which was the norm
at the vast majority of participating centres, has been associated
with early initiation of antibiotic treatment and preventive mea-
sures [19].
Although only two-thirds of the hospitals had their own diag-
nostic and/or preventive protocols, all had preventive measures
for the transmission of CDI. The high basal degree of adherence
to the preventive measures made it difficult to obtain a statistically
significant improvement in the course of the study. Nonetheless,
there was a non-significant increase in the implementation of cer-
tain preventive measures, such as hand hygiene using soap and
water instead of alcohol (since the latter has a lower activity in
the presence of spores), and in the number of centres that consid-
ered discontinuation of proton pump inhibitor (PPI) treatment
after CDI diagnosis, bearing in mind that the epidemiological
association between PPI and CDI suggests that these agents
should be withdrawn unless they are essential [20, 21].
Regarding the degree of satisfaction with the various compo-
nents of the training program, the most valued was the online
training course, in which a large number of health professionals
participated. This was followed by the recommendations on pre-
cautions for preventing CDI in health centres and the feedback
with information on global and per hospital CDI rates.
One possible limitation of the study is the use of a self-
administered, non-anonymous survey instead of an external
audit. Although a certain bias in some of the responses cannot
be ruled out, the respondents were informed that the results of
their centre would not be published individually, thus minimizing
Table 3. Survey of diagnosis and preventive measures (2011 vs. 2016)
2011 (25 hospitals) 2016 (38 hospitals)
N (%) N (%) P value
CDI study in >80% of episodes of hospital-onset diarrhoea 16 (64.0) 23 (60.5) 0.78
CDI study in >50% of episodes of community-onset diarrhoea with history of antibiotic treatment 18 (72.0) 31 (81.2) 0.37
CDI study in >50% of episodes of diarrhoea in patients admitted from nursing homes or
community healthcare centres
9 (36.0) 22 (57.9) 0.08
Only liquid or semiliquid faeces processed for CDI study 25 (100) 37 (97.4) 1.00
All the samples for CDI study sent to the laboratory in a bottle (not in a swab) 24 (96.0) 37 (97.4) 1.00
Optimal microbiological diagnostic methodologya 8 (32.0) 27 (71.1) 0.002
Availability of centre’s own protocol on diagnosis and preventive measures 15 (60.0) 25 (65.8) 0.64
Daily notification by the Microbiology Service of positive results for C. difficile 23 (92.0) 35 (92.1) 1.00
Introduction of contact precautions in all cases of CDI 25 (100) 38 (100) NS
Recommendation to wash hands with soap and water instead of alcohol 23 (92.0) 38 (100) 0.15
Duration of precautions at least 48–72 h after the end of diarrhoea 21 (84.0) 34 (89.5) 0.70
Consideration of whether to suspend antibiotic treatment 25 (100) 38 (100) NS
Consideration of whether to suspend antacid treatment 1 (4.0) 9 (23.7) 0.07
No post-treatment microbiological control performed in patients diagnosed with CDI 19 (76.0) 34 (89.5) 0.17
CDI, Clostridioides difficile infection.
NS, not significant.
aThe diagnostic method was considered optimal when a diagnostic algorithm including two or more methods of detection of toxigenic C. difficile was applied.
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the risk of such a bias. Another limitation of the study is the small
number of hospitals that participated in the surveys on adherence
to diagnostic and control measures, which made it difficult to
obtain statistically significant differences between the two surveys.
In conclusion, the application of a multimodal training strat-
egy was associated with an increase in the application of the opti-
mal diagnostic algorithm, a significant rise in the reporting of
CDI, and an increase in the number of hospitals participating
in the VINCat program in Catalonia.
Acknowledgements. The authors thank all the other members of the
VINCat Clostridioides difficile study group at Hospital Universitari Josep
Trueta: Xavier Salgado, Marta Lora; Hospital Universitari de Bellvitge:
Purificación Martos, Jordi Niubó; Hospital Universitari Germans Trias i
Pujol: Gema Fernández, Laia Castellà; Hospital Clínic Barcelona: Silvia
Valls, Gimena Santana; Hospital Universitari Mútua Terrassa: Maria López,
Esther Calbo; Corporació Sanitària Parc Taulí: Lluís Falgueras, Marta Piriz;
Hospital Universitari del Mar/Hospital de l’Esperança: Juan Pablo
Horcajada, Lluisa Sorlí; Hospital Universitari Santa Creu i Sant Pau: Joaquín
López-Contreras, Maria Àngels Cotura; Hospital Universitari Arnau de
Vilanova: Alfredo Jover-Sáenz, María Ramírez-Hidalgo; Hospital Universitari
Joan XXIII: Graciano García, Ester Picó; Hospital Verge de la Cinta de
Tortosa: Mar Olga Pérez, Marie France Domenech; Centre Hospitalari
Althaia: Dolors Mas, Rafel Pérez; Hospital General de l’Hospitalet: Ana
Coloma; Hospital de Terrassa: Laura Grau, Marta Andrés; Hospital
Universitari de Vic: Anna Vilamala, María Jesús Martínez; Hospital General
de Granollers: Jordi Cuquet, Rosa Vásquez; Hospital Universitari Sant Joan
de Reus: Antoni Castro, Simona Iftimie; Hospital Sant Rafael: Irene Sánchez,
Mercè Clarós; Hospital Santa Caterina: Íngrid Vilaró, Marisa Jofre; Hospital
Universitari Sagrat Cor: Glòria Garcia, Rosa Coll; Fundació Sanitària
d’Igualada: Montserrat Brugués, Anna Marrón; Hospital de Mataró: Goretti
Sauca, Maria Pilar Barrufet; Hospital General de Catalunya: Mariló
Marimón; Centre Mèdic Teknon: Sònia Tortajada, Mònica Gallardo;
Hospital de Barcelona: Montserrat Vaqué, Yolanda Meije; Hospital Sant
Joan Despí Moisés Broggi: Ana Coloma; Hospital Delfos: Cristina Berbel,
Irene Garcia; Clínica Girona: Josefina Serrat, Eva Palau; Hospital Comarcal
de Blanes: Àngels Garcia, Carme Gallés; Hospital de Campdevànol: Rosa
Laborda, Ana Martínez; Hospital de Figueres: Maria Carmen Burgas, Pilar
Girbal; Hospital Dos de Maig: Clara Sala, María José Moreno; Fundació
Sant Hospital de la Seu d’Urgell: Maria Teresa Ros, Joaquín Angas; Hospital
de l’Esperit Sant: Alex Smithson, Maria Teresa Bastida; Hospital Comarcal
Móra d’Ebre: José Carlos de la Fuente, Montserrat Rovira; Hospital de
Palamós: Anabel Martin-Urda, Teresa Aliu; HG Parc Sanitari Sant Joan de
Déu: Vicens Diaz-Brito, Encarna Moreno; Hospital de Sant Celoni: Carme
Agusti, Inma Peña; Hospital Municipal de Badalona: Jordi Grau, Rosa María
Benítez; Fundació Hospital Residència Sant Camil: David Blancas, Esther
Moreno; Hospital Comarcal Sant Bernabé: Sara Martínez; Hospital Sant
Jaume de Calella: Roser Ferrer, Elisenda Capdevila; Hospital d’Olot i
Comarcal de la Garrotxa: Ester Sanfeliu, Maria Montserrat Blasco; Hospital
Sant Joan de Déu de Martorell: Helena Monzón, Silvia Sancliment; Hospital
Sant Pau i Santa Tecla: Sebastián Hernández, David Castander; Hospital
Santa Maria de Lleida: Irene Montardit; Pius Hospital de Valls: Marta Sanz,
Susana Sabaté; Clínica de Ponent: Teresita Gesé, Paula Judit Hernández;
Hospital de Mollet: José María Tricas, Eva Redón; Hospital Comarcal
d’Amposta: Manel Panisello, Rosa Maria Ferré; Hospital Comarcal de l’Alt
Penedès: Maria Cuscó, Lourdes Gabarró; Clínica Quirón: Josep Farguell;
Hospital del Vendrell: Elisabet Calaf, David Castander; Clínica del Vallès:
Maria Carmen Fernández, Esther Oviedo; ICO l’Hospitalet de Llobregat:
Carlota Gudiol, Adaia Albasanz-Puig; ICO Badalona: Montserrat Jiménez;
Centre Coordinador VINCat: Gonçalo Rodrigues. The authors thank
Angeles Jaen (Fundació Docència i Recerca Mútua Terrassa) for her assistance
in the statistical analysis.
Author ORCIDs. N. Sopena, 0000-0001-6382-9500.
Author contributions. NS, NF, FB, JP and FG were involved in the concep-
tion and design of the study. NF, EL, JP and AH were involved in data acqui-
sition. FB, NF, NS and MP were involved in analysis and interpretation of data.
NS, NF and FB drafted the manuscript. All authors revised critically the manu-
script and approved the final version to be submitted.
Financial support. This research did not receive any specific grant from
funding agencies in the public, commercial or not-for-profit sectors.
Conflict of interest. None.
Ethical standards. Written informed consent was considered not necessary
for the study, given that the study did not involve any patient interventions.
The confidential information of the patients was protected according to
national normative and was anonymised for the purposes of this clinical
study. The participation of health professionals was voluntary. This manu-
script has been revised for its publication by the Clinical Research Ethics
Committee of Bellvitge University Hospital (ref PR 435/18).
References
1. Mc Donald LC et al. (2018) Clinical practice guidelines for Clostridium
difficile infection in adults and children: 2017 update by the Infectious
Diseases Society of America (IDSA) and Society for Healthcare
Epidemiology of America (SHEA). Clinical Infectious Diseases 20, 1–48.
2. Durovic A, Widmer AF and Tschdin-Stter S (2018) New insights into
transmission of Clostridium difficile infection-narrative review. Clinical
Microbiology and Infection 24, 483–492.
3. Crobach MJ et al. (2016) European Society of Clinical Microbiology and
Infectious Diseases update of the diagnostic guidance document for
Clostridium difficile infection. Clinical Microbiology and Infection 22
(suppl. 4), S63–S81.
4. Bauer MP et al. (2011) Clostridium difficile infection in Europe: a
hospital-based survey. Lancet 377, 63–73.
5. Freeman J et al. (2010) The changing epidemiology of Clostridium
difficile infections. Clinical Microbiology Reviews 23, 529–549.
6. Asensio A et al. (2008) Increasing rates in Clostridium difficile infections
(CDI) among hospitalised patients, Spain 1999–2007. European Surveillance
13, pii: 18943.
7. Davies KA et al. (2014) Underdiagnosis of Clostridium difficile across
Europe: the European, multicenter, prospective, biannual, point-prevalence
study of Clostridium difficile infection in hospitalized patients with diarrhea
(EUCLID). Lancet Infectious Diseases 14, 1208–1219.
8. Fayerberg E, Bouchard J and Kellie SM (2013) Knowledge, attitudes and
practice regarding Clostridium difficile: a survey of physicians in an aca-
demic medical center. American Journal of Infection Control 41, 266–269.
9. Gudiol F et al. (2012) The development and successful implementation of
the VINCat Program. Enfermedades Infecciosas Microbiología Clínica 30
(suppl. 3), 3–6.
10. Mavros MN et al. (2012) Underestimation of Clostridium difficile infec-
tion among clinicians: an international survey. European Journal of
Clinical Microbiology and Infectious Disesases 31, 2439–2444.
11. Alicino C et al. (2016) Increasing incidence of Clostridium difficile infec-
tions: results from a 5-year retrospective study in a large teaching hospital
in the Italian region with the oldest population. Epidemiology and
Infection 144, 2517–2526.
12. Khanafer N et al. (2016) Clostridium difficile infection in a French univer-
sity hospital. Eight years of prospective surveillance study. Medicine
(Baltimore) 95, e3874.
13. Rizzardi K et al. (2018) National surveillance for Clostridioides difficile
infection, Sweden, 2009–2016. Emerging Infectious Diseases 24, 1617–
1624.
14. Bogaty C et al. (2017) Trends in the use of laboratory tests for the diag-
nosis of Clostridium difficile infection and association with incidence rates
in Quebec, Canada, 2010–2014. American Journal of Infection Control 45,
964–968.
15. Longtin Y et al. (2013) Impact of the type of diagnostic assay on
Clostridium difficile infection and complication rates in a mandatory
reporting program. Clinical Infectious Diseases 56, 67–73.
16. Krishna A et al. (2017) Prevalence of Clostridium difficile infection in
acute care hospitals, long-term care facilities and outpatient clinics: is
6 N. Sopena et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268819001080
Downloaded from https://www.cambridge.org/core. IP address: 139.59.165.54, on 26 Oct 2020 at 09:27:11, subject to the Cambridge Core terms of use, available at
Clostridium difficile infection underdiagnosed in long-term care facility
patients? American Journal of Infection Control 45, 1157–1159.
17. Chitnis AS et al. (2013) Epidemiology of community-associated
Clostridium difficile infection, 2009 through 2011. JAMA Internal
Medicine 173, 1359–1367.
18. Na’amnih W et al. (2017) Incidence and risk factors for community and
hospital acquisition of Clostridium difficile infection in the Tel Aviv
Sourasky Medical Center. Infection Control Hospital Epidemiology 38,
912–920.
19. Polen CB et al. (2018) Impact of real-time notification of Clostridium
difficile test results and early initiation of effective antimicrobial therapy.
American Journal of Infection Control 46, 538–541.
20. Trifan A et al. (2017) Proton pump inhibitors therapy and risk of
Clostridium difficile infection: systematic review and meta-analysis.
World Journal of Gastroenterology 23, 6500–6515.
21. Riley TV and Kimura T (2018) The epidemiology of Clostridium difficile
infection in Japan: a systematic review. Infection Diseases Therapy 7,
39–70.
Epidemiology and Infection 7
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268819001080
Downloaded from https://www.cambridge.org/core. IP address: 139.59.165.54, on 26 Oct 2020 at 09:27:11, subject to the Cambridge Core terms of use, available at
